Cargando…

Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran

Venous thromboembolism (VTE) is a disease state that carries significant morbidity and mortality, and is a known cause of preventable death in hospitalized and orthopedic surgical patients. There are many identifiable risk factors for VTE, yet up to half of VTE incident cases have no identifiable ri...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fanola, Christina L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455861/ https://www.ncbi.nlm.nih.gov/pubmed/26064057 http://dx.doi.org/10.2147/VHRM.S62595

Ejemplares similares

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
por: Leung, Timothy S, et al.
Publicado: (2015)

Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia
por: Brandão, Leonardo R., et al.
Publicado: (2022)

Venous thromboembolism: current management
por: Stevens, Hannah, et al.
Publicado: (2019)

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
por: Stevanović, J., et al.
Publicado: (2016)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
por: Al-Ghafry, Maha, et al.
Publicado: (2022)

Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER(®), RE-COVER™ II, and RE-MEDY™
por: Feuring, Martin, et al.
Publicado: (2017)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
por: Montoya, Roberto C., et al.
Publicado: (2012)

Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
por: Bosch, Alessandra, et al.
Publicado: (2020)

Current Challenges in Diagnosis of Venous Thromboembolism
por: Liederman, Zachary, et al.
Publicado: (2020)

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
por: Dahl, Ola E
Publicado: (2012)

Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism
por: Albisetti, Manuela, et al.
Publicado: (2018)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

Risk impact of edoxaban in the management of stroke and venous thromboembolism
por: Hurst, Katherine V, et al.
Publicado: (2016)

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
por: Röshammar, Daniel, et al.
Publicado: (2021)

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism
por: Tellor, Katie B, et al.
Publicado: (2016)

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve
por: Abdel-Razeq, Hikmat
Publicado: (2010)

Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
por: Stevens, Hannah, et al.
Publicado: (2020)

Venous Thromboembolism: Classification, Risk Factors, Diagnosis, and Management
por: Moheimani, Fatemeh, et al.
Publicado: (2011)

Carotid Thromboembolism Associated with Nephrotic Syndrome Treated with Dabigatran
por: Sasaki, Yosuke, et al.
Publicado: (2014)

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial
por: Mirdamadi, Ahmad, et al.
Publicado: (2014)

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism
por: Albisetti, Manuela, et al.
Publicado: (2017)

Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy
por: Edebiri, Osasere, et al.
Publicado: (2022)

Current Status of the Korean Venous Thromboembolism Registry
por: Oh, Doyeun
Publicado: (2011)

Venous Thromboembolism – Current Diagnostic and Treatment Modalities
por: Bosevski, Marijan, et al.
Publicado: (2016)

Assessing the risk of recurrent venous thromboembolism – a practical approach
por: Fahrni, Jennifer, et al.
Publicado: (2015)

The Benefits and Imperative of Venous Thromboembolism Risk Screening for Hospitalized Patients: A Systematic Review
por: Bakhsh, Ebtisam
Publicado: (2023)

Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
por: Luciani, Matteo, et al.
Publicado: (2018)

Current status of treatment of cancer-associated venous thromboembolism
por: Xiong, Wei
Publicado: (2021)

Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
por: Kim, Sang-A, et al.
Publicado: (2019)

Recent advances in the management of venous thromboembolism
por: Ageno, Walter
Publicado: (2010)

Thrombotic Risk in Cancer Patients: Diagnosis and Management of Venous Thromboembolism
por: Citro, Rodolfo, et al.
Publicado: (2020)

Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
por: Lee, Hong Lyeol, et al.
Publicado: (2019)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks?
por: Patel, Rashmi
Publicado: (2015)

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2017)

Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy
por: Goldstein, Zil, et al.
Publicado: (2019)

Venous Thromboembolism in Children: From Diagnosis to Management
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
por: Di, Wenjuan, et al.
Publicado: (2021)

Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism
por: Mahajerin, Arash, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7c5fmnemobds1943b8m34s96id